- Version
- Download 10439
- File Size 1.03 MB
- File Count 1
- Create Date November 4, 2020
- Last Updated February 22, 2022
Guidelines for the Pharmacological Management of Overactive Bladder Disease in Adults in Primary Care
Overactive Bladder (OAB)
Mirabegron
NICE TA290
Betmiga
Regurin
Vesicare
Detrunorm
Detrusitol
Lyrinel
Toviaz
Fesoteradine
Ditropan
Tolterodine
Oxybutynin
Oxybutynin MR
Trospium
Solifenacin
Mirabegron
Attached Files
File | Action |
---|---|
OAB guidance minor update Feb 2022 FINAL.pdf | Download |